Deciphera Pharmaceuticals (DCPH US)

Analysis

Health Care • United States

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.

Refresh

Company Presentation • 08 Feb 2024 20:00

Corporate Presentation

Company Presentation • 06 Feb 2024 06:36

Corporate Presentation

Company Presentation • 01 Nov 2023 21:00

Investor Presentation

Company Presentation • 30 Oct 2023 20:00

Q3 2023

Company Presentation • 09 Aug 2023 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate Presentation

Corporate Presentation

Investor Presentation

Q3 2023

Q2 2023